RANI
Rani Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.87
+1.54%Margins
Gross margin
96.7%
EBITDA margin
-658.2%
EBIT margin
-675.8%
Net margin
-618.0%
FCF margin
-417.0%
-76.8%
Return on equity
-49.5%
Return on assets
-77.0%
Return on invested capital
0.09x
Asset turnover
-$20.3M
Cash from operations
$0.46
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026